FORT WORTH, Texas, March 10 /PRNewswire-FirstCall/ -- Wound Care Innovations, LLC, a subsidiary of Wound Management Technologies, Inc., (OTC Bulletin Board: WNDM), announced today that it has entered into a vendor agreement with Independent Medical Co-Op, Inc. (IMCO), the nation's premier association for medical product manufacturers and independent distributors.
IMCO vendors are carefully selected on quality, price, service, integrity and market acceptance, as well as their exceptional support for IMCO members and their customers. Only one of 20 vendors qualify to become an IMCO vendor. Wound Care Innovation's patented advanced wound care collagen product, CellerateRx(R), was selected as a unique product that has unprecedented capabilities and benefits through all phases of wound healing and is FDA cleared for use on all wound types, except for 3rd degree burns.
"As an IMCO vendor, Wound Care Innovations joins an elite growing network of independent distributors with over 1,000 sales people to market CellerateRx throughout the U.S.," said Cathy Bradshaw, president of Wound Care Innovations. "IMCO has grown into a major distribution force in the physician and nursing home markets, while expanding acute care and other market segments. We are excited with the new sales and marketing opportunities this new relationship brings to Wound Care Innovations."
Established in 1981, IMCO is a U.S. leader in medical supply distribution. The Company has established a trusted network of the best independent distributors in the healthcare industry. With over 125 member locations throughout North America, Puerto Rico and the US Virgin Islands, IMCO provides coverage in the Physician, Hospital, Blood Banks, Nursing Home, Lab, Industrial, Dental, Home Care, Government, EMS, and Veterinary markets.
|SOURCE Wound Management Technologies, Inc.|
Copyright©2009 PR Newswire.
All rights reserved